BINOTTO, GIANNI
 Distribuzione geografica
Continente #
NA - Nord America 2.142
AS - Asia 797
EU - Europa 739
AF - Africa 298
SA - Sud America 237
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 13
Totale 4.249
Nazione #
US - Stati Uniti d'America 2.041
SG - Singapore 238
CN - Cina 174
BR - Brasile 153
DE - Germania 137
IT - Italia 129
HK - Hong Kong 120
FI - Finlandia 79
PL - Polonia 42
RU - Federazione Russa 37
SE - Svezia 32
NL - Olanda 30
CI - Costa d'Avorio 27
VN - Vietnam 23
FR - Francia 22
GB - Regno Unito 22
UA - Ucraina 22
AR - Argentina 17
IN - India 17
SN - Senegal 15
TR - Turchia 15
GN - Guinea 14
AZ - Azerbaigian 12
EC - Ecuador 12
JP - Giappone 12
KG - Kirghizistan 12
AO - Angola 11
ID - Indonesia 11
AT - Austria 10
CH - Svizzera 10
ES - Italia 10
HR - Croazia 10
IQ - Iraq 10
PK - Pakistan 10
PY - Paraguay 10
ZA - Sudafrica 10
ZW - Zimbabwe 10
BF - Burkina Faso 9
CR - Costa Rica 9
GA - Gabon 9
GT - Guatemala 9
LY - Libia 9
MA - Marocco 9
MK - Macedonia 9
MU - Mauritius 9
NP - Nepal 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
AM - Armenia 8
BA - Bosnia-Erzegovina 8
CW - ???statistics.table.value.countryCode.CW??? 8
GE - Georgia 8
GR - Grecia 8
IE - Irlanda 8
MD - Moldavia 8
ML - Mali 8
MX - Messico 8
SD - Sudan 8
AF - Afghanistan, Repubblica islamica di 7
BY - Bielorussia 7
CG - Congo 7
CM - Camerun 7
CO - Colombia 7
CZ - Repubblica Ceca 7
EG - Egitto 7
GF - Guiana Francese 7
HN - Honduras 7
IL - Israele 7
JM - Giamaica 7
MZ - Mozambico 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
PA - Panama 7
PE - Perù 7
SK - Slovacchia (Repubblica Slovacca) 7
TJ - Tagikistan 7
UY - Uruguay 7
AD - Andorra 6
BJ - Benin 6
BO - Bolivia 6
BW - Botswana 6
BZ - Belize 6
CY - Cipro 6
ET - Etiopia 6
IS - Islanda 6
JO - Giordania 6
KE - Kenya 6
KH - Cambogia 6
KR - Corea 6
KZ - Kazakistan 6
LC - Santa Lucia 6
LV - Lettonia 6
ME - Montenegro 6
PR - Porto Rico 6
PT - Portogallo 6
RE - Reunion 6
RS - Serbia 6
SO - Somalia 6
TT - Trinidad e Tobago 6
UG - Uganda 6
Totale 4.015
Città #
Ashburn 247
Chandler 223
Fairfield 196
Woodbridge 176
Singapore 155
Ann Arbor 148
Houston 122
Hong Kong 114
Cambridge 86
Seattle 80
Beijing 66
Wilmington 62
Jacksonville 60
Santa Clara 57
Boardman 48
Munich 41
Princeton 39
Bytom 38
Helsinki 32
Medford 28
Abidjan 27
Padova 27
San Diego 27
Frankfurt am Main 26
Los Angeles 22
Turku 18
Chicago 16
Des Moines 16
Nanjing 16
Dakar 15
Roxbury 14
Conakry 13
Baku 12
Hefei 12
São Paulo 12
Bishkek 11
Luanda 11
New York 10
Washington 10
Harare 9
Istanbul 9
Libreville 9
Vienna 9
Bamako 8
Dublin 8
Milan 8
Nuremberg 8
Rio de Janeiro 8
Buffalo 7
Dushanbe 7
Guangzhou 7
Ho Chi Minh City 7
Lappeenranta 7
Ouagadougou 7
Panama City 7
Rome 7
Tbilisi 7
Zagreb 7
Amman 6
Andorra la Vella 6
Athens 6
Brazzaville 6
Castries 6
Cayenne 6
Chisinau 6
Dallas 6
Guayaquil 6
Jakarta 6
Kampala 6
Kingston 6
Montevideo 6
Nairobi 6
Phnom Penh 6
San José 6
Skopje 6
Tashkent 6
Tripoli 6
Willemstad 6
Addis Ababa 5
Asunción 5
Auckland 5
Boston 5
Brasília 5
Cotonou 5
Djibouti 5
Douala 5
Düsseldorf 5
Khartoum 5
Kinshasa 5
Kyoto 5
Legnaro 5
Lima 5
London 5
Maputo 5
Minsk 5
Niamey 5
Nouakchott 5
Podgorica 5
Riga 5
Tallinn 5
Totale 2.709
Nome #
Successful control of Blastoschizomyces capitatus infection in three consecutive acute leukaemia patients despite initial unresponsiveness to liposomal amphotericin B. 181
Diagnostic and prognostic value of low percentage of glycosylated ferritin in acquired hemophagocytic lymphohistiocytosis: A single-center study 179
Comparative Analysis of NK Receptor and T-Cell Receptor Repertoires in Patients with Chronic Myeloid Leukemia Treated with Different Tyrosine Kinase Inhibitors 172
Chronic Myeloid Leukemia With Myelofibrosis-Like Features. Clues of Accelerated Phase? 171
Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis. 165
Histology of the spleen in Immune Thrombocytopenia: clinical-pathological characterization and prognostic implications 164
Imatinib-treated Chronic Myeloid Leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response. 160
EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia. 151
Antiapoptotic effects of IL-15 on pulmonary Tc1 cells of patients with human immunodeficiency virus infection 146
Pneumonia mimicking lung leukemic infiltration 124
Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study 121
Second primary malignancy in myelofibrosis patients treated with ruxolitinib 121
Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL) 120
Ifosfamide and cyclophosphamide: Effects on immunosurveillance 117
Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience 116
The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population 116
Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases 113
Phenotypic and functional analysis of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL) 111
Pneumonia Mimicking Lung Leukemic Infiltration 105
Relevance of bone marrow histology in challenging cases of Acute Myeloid Leukemia 103
Longitudinal strain analysis allows the identification of subclinical deterioration of right ventricular myocardial function in patients with cancer therapy-related left ventricular dysfunction 99
T-cell receptor molecular analysis in paediatric patients undergoing allogenic bone marrow transplantation 99
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis 98
Analysis of lymphocyte subsets and T-Cell receptor repertoire in allogeneic bone marrow transplanted patients. 97
Thrombopoietin receptor agonists increase splenic regulatory T-cell numbers in immune thrombocytopenia 96
Chemokine receptors and adhesion molecules involvement in multiple myeloma. 95
Combination of eutos score and 3-month bcr-abl transcript level identifies a group of good-risk chronic myeloid leukemia patients with favourable response to frontline imatinib therapy. 95
Accessory spleens recapitulate the immune microenvironment of the main spleen in immune thrombocytopenia 94
Chemokine receptors involvement in B-cell lymphoproliferative disorders. 93
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome 93
Homestatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. 92
Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1-JAK2 positive myeloid sarcoma and acute B-lymphoblastic leukemia 88
Non-Hodgkin's lymphomas express different chemokine receptor profiles. Phenotypic and functional analysis. 86
Of drills and bones: Giovanni Ghedini and the origin of bone marrow biopsy 84
Apoptotic effect of dexamethasone and cyclosporin A in malignant cells of B-CLL patients. 80
T-cell imbalance in hairy cell leucemia is related to the bias of T-cell receptor variable region usage 70
9p24/JAK2 rearrangements in myeloid neoplasms: from myelodysplastic syndromes to myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions 43
Quality of life and physicians' perception in myelodysplastic syndromes 40
Totale 4.298
Categoria #
all - tutte 16.310
article - articoli 15.738
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021182 0 0 0 17 19 23 9 15 41 17 27 14
2021/2022350 2 43 19 20 24 18 9 35 46 3 38 93
2022/2023402 79 46 8 50 67 52 1 29 50 9 8 3
2023/2024270 17 24 41 26 20 44 16 21 10 16 11 24
2024/20251.030 7 68 50 28 101 36 66 92 94 54 184 250
2025/20261.248 220 310 517 201 0 0 0 0 0 0 0 0
Totale 4.298